Price Adrian is an activist shareholder in Alaunos Therapeutics with notable voting influence and has made recent disclosures through SEC Schedule 13D filings signaling an active investment position in the company.
II. Letters & Presentations
Nil
III. Significant companies
Below is a list of company engagements where the filer has filed a Schedule 13D and/or engaged in a proxy campaign. As the filer does not file a Form 13F, current ownership information is not available.
Members Only · Snowball Research
Continue reading this report
Unlock the full analysis, investor activity breakdown, and complete commentary.
Try first
Free Trial
Submit a request with your professional email address and we'll send you a sample report.